Cannabis Patient Care™ Announces Members of Editorial Advisory Board
Eight distinguished individuals from across the United States will assemble to aid in the publication's fulfillment of its editorial mission to educate the medical community on cannabis treatments.
Cannabis Patient Care™, a leading multimedia platform dedicated to advancing medical research, education, and treatment in the cannabis industry, is pleased to officially announce the first eight members of its newly launched editorial advisory board.
"We are very grateful to welcome eight talented and well-respected members of the cannabis industry to our editorial advisory board," said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of Cannabis Patient Care™. "Through their experiences and contributions within the field, we will be able to gain new perspectives and ideas on cannabis treatments for patients and the cannabis community as a whole. I am looking forward to seeing the brilliant ideas that each of the new members will bring to the publication."
The Cannabis Patient Care™ editorial advisory board includes the following:
- Stanley Atkins, owner, The Good Medic LLC.
- Ann M. Brum, founder and CEO, Joint Venture & Co.
- Joshua Crossney, president, CEO, and founder, Cannabis Science Conference.
- Me Fuimaono-Poe, FNP-BC, medical director and founder, Malie Cannabis Clinic.
- Stephen Mandile, veteran, activist, and consultant at Joint Venture & Co.
- Heather Manus, RN, CEO and founder member, Cannabis Nurses Network.
- Marion McNabb, DrPH, MPH, president, Cannabis Center of Excellence, Inc.
- Patricia A. Patton, founder, Cannabis Business Alliance.
The advisory board members will work in collaboration to help Cannabis Patient Care™ achieve its editorial mission: to educate the medical community on the viable treatment options patients are experiencing with cannabis and the ongoing research into cannabis and cannabinoids worldwide. With recognized expertise ranging from medical research to advocacy work and personal experience as patients, the board members will also perform a range of functions, such as suggesting authors and topics for coverage and providing the editorial team with general direction and feedback.
"Several of our board members were instrumental in helping to launch Cannabis Patient Care™ in November 2020 and I am delighted to continue our relationship with them," said Megan L'Heureux, group editorial director of Cannabis Patient Care™. "Each board member brings a unique perspective to the publication and I am thrilled to be working with them on our future issues and shared goal of educating the community."
For more information on Cannabis Patient Care™ editorial advisory board, click here.
About Cannabis Patient Care™
Cannabis Patient Care™ magazine is an educational resource for patients, doctors, nurses, pharmacists, and caregivers on the latest research, benefits, and treatment options cannabis provides for a variety of illnesses. Each issue of the publication will focus on a specific disease or ailment for which cannabis has been shown to be an effective remedy. The brand will cover the current research, patient testimonials, medical perspectives, and advocacy work. The mission of Cannabis Patient Care™ is to educate the medical community on the viable treatment options patients are experiencing with cannabis and the ongoing research into cannabis and cannabinoids worldwide. Cannabis Patient Care™ is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.
Cannabis Patient Care™ Media Contact
Alexandra Ventura, 609-716-7777
aventura@mjhlifesciences.com
Medical Cannabis Campaigning with Americans for Safe Access
September 4th 2024As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.
